WGRX
Wellgistics Health, Inc.
NASDAQ · Healthcare · Medical - Distribution · US
$3.52
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 8.0M | 23.3M | 18.1M | — | 32.8M |
| Cost of Revenue | 18.1M | 33.0M | 16.4M | — | 27.0M |
| Gross Profit | (10.0M) | (9.6M) | 1.8M | — | 5.7M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | 375.00 | 1.4K |
| SG&A Expense | 48.1M | 71.6M | 6.8M | 2.9M | 7.1M |
| General & Admin Expense | 46.2M | 70.3M | 6.8M | 2.9M | 7.1M |
| Selling & Marketing Expense | 1.9M | 1.2M | — | — | — |
| Other Expenses | (802.9K) | — | 1.1M | (375.00) | 2.1M |
| Total Operating Expenses | 47.3M | 71.6M | 7.9M | 2.9M | 9.2M |
| Cost and Expenses | 65.4M | 104.5M | 24.3M | 2.9M | 36.2M |
| Operating Income (EBIT) | (57.7M) | (81.2M) | (6.1M) | (2.9M) | (3.4M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | (1.3M) | 4.6M | 831.5K | 15.1K | 287.2K |
| Net Interest Income | (228.3K) | (4.6M) | (831.5K) | (15.1K) | (287.2K) |
| Other Non-Op Income/Expense | (30.6M) | (20.1M) | (711.1K) | (15.1K) | 678.9K |
| Non-Operating Income (excl Interest) | 1.4M | 15.5M | (120.4K) | — | (966.1K) |
| EBT (Pre-Tax Income) | (88.3M) | (101.3M) | (6.9M) | (2.9M) | (2.7M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (88.3M) | (101.3M) | (6.9M) | (2.9M) | (2.7M) |
| Earnings from Cont. Ops | (88.3M) | (101.3M) | (6.9M) | (2.9M) | (2.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (88.3M) | (101.3M) | (6.9M) | (2.9M) | (2.7M) |
| Per Share | |||||
| Basic EPS | ($47.33) | ($71.50) | ($6.50) | ($3.00) | ($2.91) |
| Diluted EPS | ($47.33) | ($71.50) | ($6.50) | ($3.00) | ($2.91) |
| Revenue Per Share | $3.12 | $16.44 | $17.45 | $0.00 | $34.68 |
| Shares | |||||
| Basic Shares Outstanding | 2.6M | 1.4M | 1.0M | 894400 | 945042 |
| Diluted Shares Outstanding | 2.6M | 1.4M | 1.0M | 894400 | 945042 |
| Profitability Metrics | |||||
| EBITDA | (56.8M) | (93.5M) | (4.9M) | (2.9M) | (369.0K) |
| D&A | 2.3M | 3.2M | 1.1M | — | 2.1M |
| EBIT | (51.7M) | (96.7M) | (6.0M) | (2.9M) | (2.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026